Washington, March 26 (Petra) -- The U.S. Food and Drug Administration (FDA) announced, late Wednesday, new emergency protocols allowing the plasma of those who've recovered from the novel coronavirus to treat patients who are critically ill with COVID-19.
The FDA's decision comes a day after New York Governor Andew Cuomo announced that the state's health department planned to begin treating the sickest coronavirus patients with antibody-rich plasma extracted from the blood of those who've recovered.
The FDA said it is possible that this treatment, convalescent plasma, contains antibodies to SARS-CoV-2 (the virus that causes COVID-19) and might be effective against the infection.
Chief of molecular microbiology and immunology at Johns Hopkins Bloomberg School of Public Health, Dr. Arturo Casadevall, has advocated for the plasma treatment, saying this move is a "big step" forward.
"It has a high likelihood of working but we won't know whether it works until its done", he said, adding "we do know based on history it has a good chance."